Hypertension, Vol 14, 261-268, Copyright © 1989 by American Heart Association
AM Richards, EA Espiner, H Ikram and TG Yandle
To ascertain whether small shifts in plasma atrial natriuretic factor (ANF)
exerted biological effects in hypertension, we studied the renal,
hemodynamic, and hormonal effects of ANF [human ANF-(99-126)] infused at a
dose (0.75 pmol/kg/min for 3 hours) that would induce changes in plasma ANF
confined to the normal, resting range, in a group of six young men with
uncomplicated, mild essential hypertension. During ANF infusions, the
patients excreted 11.8 +/- 2.0 mmol (mean +/- SEM) sodium more than during
the time-matched placebo phase natriuresis (p less than 0.001, mean
increase of 53% above placebo values). Urinary excretion of cyclic
guanosine monophosphate rose to more than double (212%, p less than 0.001)
placebo values. Plasma renin activity (0.4 +/- 0.05 vs. 0.9 +/- 0.12
nmol/l/hr, p less than 0.0001) and aldosterone concentrations (102 +/- 4
vs. 184 +/- 47 pmol/l, p less than 0.05) were clearly suppressed during
administration of ANF. Plasma norepinephrine also fell significantly below
placebo values (268 +/- 17 vs. 439 +/- 35 pg/ml, p less than 0.05). Urine
volume, the excretion of electrolytes other than sodium, hematocrit,
effective renal plasma flow, glomerular filtration rate, and filtration
fraction were unaffected by ANF. Similarly, plasma concentrations of
epinephrine, arginine vasopressin, adrenocorticotropic hormone, and
cortisol were unchanged. Blood pressure and heart rate were unchanged.
Minor perturbations in plasma ANF concentrations exert clear biological
effects in patients with mild essential hypertension. These data suggest
that such minor shifts in plasma ANF are of physiological relevance in mild
hypertension and probably contribute to volume homeostasis in this
condition.
ARTICLES
Atrial natriuretic factor in hypertension: bioactivity at normal plasma levels
Department of Cardiology, Princess Margaret Hospital, Christchurch, New Zealand.
This article has been cited by other articles:
![]() |
V. M. Campese, M. Tawadrous, R. Bigazzi, S. Bianchi, A. S. Mann, S. Oparil, and L. Raij Salt Intake and Plasma Atrial Natriuretic Peptide and Nitric Oxide in Hypertension Hypertension, September 1, 1996; 28(3): 335 - 340. [Abstract] [Full Text] |
||||
![]() |
G. B. Pidgeon, A. M. Richards, M. G. Nicholls, E. A. Espiner, T. G. Yandle, and C. Frampton Differing Metabolism and Bioactivity of Atrial and Brain Natriuretic Peptides in Essential Hypertension Hypertension, April 1, 1996; 27(4): 906 - 913. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |